Introduction
until 2014, when it was surpassed by the ST796 clone (22) -largely due to its widespread 82 dissemination throughout Victoria and southeastern Australia (23) . 83 Along with the spread of the vanB-associated ST796 clone, there has been a recent, 84 dramatic increase in vanA-VREfm; since 2011, the prevalence of vanA-VREfm bacteremia, 85 as measured by these sentinel surveys, increased from <1% (2/341) to 21% (90/408 isolates 86 genotyped) in 2016 (24) . The reasons for this increase remain unclear, but multiple STs 87 appear to be involved. A retrospective study examining vanA-VREfm (screening and clinical 88 isolates) across four Australian hospitals from 2011-2013 (25) suggested this increase could 89 not be attributed to a single ST or vanA-harbouring plasmid; however, this was based on a 90 convenience sample of only 18 isolates from across the whole country, making this 91
inconclusive. 92
To further explore the potential reasons for the shift in van genotype, and increase our 93 understanding of the molecular epidemiology of VREfm, we conducted a population-level 94 study of VREfm in the State of Victoria -the second most inhabited State in Australia 95 (http://www.abs.gov.au/AUSSTATS/). All VREfm isolates from colonization and clinical 96 infection detected across the State over a month were subjected to whole genome sequencing, 97 as well as isolates from VSEfm bacteremia. In doing so, we provide an in-depth assessment 98 of the genomic diversity of E. faecium and novel insights into the epidemiology of VREfm in 99 this region. 100
101

Materials and Methods 102
Study design and population. gene content of vanA-harbouring plasmids, these plasmids were aligned to one another using 158 progressiveMauve (build date 2014- [12] [13] [14] [15] [16] [17] [18] [19] and visualized in Geneious (v.9.1.7, (42)). 159 Tn1546 transposons were identified and genes were manually compared across plasmids. 160
Victorian isolates in global context. 161
To assess how Victorian E. faecium strains fit in the global context, we re-ran our analyses 162 including 877 additional strains from Europe (872), North America (2), Africa (2) and Asia 163 (Israel; 1) (43) (44) (45) (46) , and isolates from the Welcome Trust Sanger BSAC Resistance 164 Surveillance Project (from NCBI BioProject PRJEB344). A maximum likelihood tree was 165 produced using IQ-TREE (v. In total, 321 isolates (from 286 patients) were VREfm -20 of which were from BSI 183 (from 17 patients). Ten VSEfm isolates (from ten patients) were also collected; one of these 184 was likely a false negative, as the patient also had a vanA-VREfm isolated from blood 185 collected the same day (further detail in the Appendix). Thus, 27 patients had E. faecium 186 bacteremia over this period; an incidence of 5.5/100,000 when extrapolated to one year. 187
Most patients (n=257, 87.1%) were from hospitals in major metropolitan centers, 188 compared to rural areas (n=29, 9.8%), consistent with the geographical distribution of the 189 population in this State. Overall, 35 Prior to adjusting for recombination, there were a median of 20 core SNPs between study 224 isolates and the reference (IQR 14-2,653); adjusting for recombination reduced this to a 225 median of 12 core SNPs (IQR 9-238). An alignment of these adjusted core SNPs was used to 226 produce a maximum likelihood tree (Figure 2 ; recombination blocks are shown in Figure  227 A2). Many branches had very low bootstrap support, therefore BAPS was used to validate 228 clusters.
Five major BAPS groups were identified, which were largely consistent with the 230 phylogeny (Figure 2 were separated by a median of 257 core SNPs (IQR 167-312). Excluding repeat samples from 235 the same patient, 81 pairs of isolates were within one SNP. Sixty-six of these pairs (81%) 236 were isolated at the same hospitals as one another (H1, H3, H5), while the remainder were 237 predominantly from different HCNs (see Figure A3 ). BAPS-3 was comprised of a single 238 VSEfm isolate from ST54, which was over 3,900 SNPs from other isolates (not shown in 239 As we hypothesized there were differences in diversity between isolates with different 250
VREfm genotypes, vanA-VREfm and vanB-VREfm were analyzed separately. vanA-VREfm 251 were significantly less diverse within hospitals compared to between them ( Figure 3B , 252 p=0.0001), suggesting multiple, independent introduction events with subsequent intra-253 hospital transmission. In contrast, vanB-VREfm was more diverse within hospitals vs.between them (Figure 3C ), p=0.0001), consistent with wide-spread dissemination and long-255 term establishment of these strains across institutions within the Victorian healthcare system. 256
Virulence. 257
Isolates were interrogated for the presence of putative virulence factors; as shown in Figure  258 2, only two isolates (both ST17) had the cylA gene which is required for expression of 259 cytolysin (49). No genes encoding hyaluronidase (hyl Efm (50)), agglutination substance 260 (agg/asa1 (51) or gelatinase (gelE (52)) were detected; the latter two genes are thought to be 261 more prevalent in E. faecalis than E. faecium (53). 262
Microbial surface components recognizing adhesive matrix molecules including acm 263 (54), which has been found predominantly in clinical isolates, as well as ecbA (55) (56) . 270
Finally, the gene esp, which has previously been associated with hospital outbreaks 271 (57) and encodes enterococcal surface protein (58), was investigated. While repeat regions 272 made it impossible to completely assemble esp using short-read data (see Appendix, Figure  273 A4), we found that 266 isolates had at least 80% coverage (81.6% of vanA-VREfm; 86.2% of 274 vanB-VREfm), suggesting that these isolates were likely esp-positive. In this context, esp was 275 more prevalent in bacteremia due to VREfm than VSEfm (17/20 vs. 1/9, p=0.0001, excluding 276 the VSEfm that had likely lost the vanA operon).
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The vanA-harbouring plasmid from one isolate per ST was completely assembled 278 using long-read data; no putative virulence genes were found to co-localize with vanA on the 279 same plasmid (Figure A5) . 280
Comparative genomics of vanA-VREfm. 281
The vanA-harbouring plasmids from ST78 and ST796 had the greatest homology (Figure 4 (Table A4 ). The vanA-harbouring plasmid from ST203 was most closely related to plasmids 296 from several STs of VREfm isolated in Western Australia and Queensland (25), while the 297 plasmid from ST1421 was closely-related to that from another ST1421 E. faecium, isolated in 298 New South Wales in 2014 (59) ( Table A4) . 299
Phylogenetic analysis based on core SNPs from Victorian isolates and global E. 300 faecium strains showed that, with the exception of those from ST796, Victorian isolates werewidely distributed across the tree ( Figure A7) (23) . 315
Another possibility was that a single vanA-harbouring plasmid and/or Tn1546 316 transposon was being transmitted within and across different STs, as has been shown in 317 Denmark (46) . As a unique vanA-harbouring plasmid was present in representatives from 318 each ST, and nearly all had different Tn1546 transposons, this suggests that horizontal gene 319 transfer is not the sole driver of vanA-VREfm in Victoria. 320
Finally, we assessed whether there were differences in putative virulence factors 321 between our isolates, and those from other studies/settings. Overall, few putative virulence 322 factors were identified, and their prevalence was largely consistent with previous data from 323 vanB-VREfm in Australia (64), and similar to or lower than those found in vanA-VREfm 324 from settings (e.g., in China (65) or Brazil (66) ). While much is still unknown about 325 virulence factors in VREfm (compared to Enterococcus faecalis), this suggests the rise invanA-VREfm in Australia, and the continued success of vanB-VREfm, is not due to changes 327 in virulence. Consistent with this, the rate of E. faecium BSI in our study was similar to that 328 of another population-based study in Denmark (3). This has important implications for 329 hospital infection control; as the patient population affected by VREfm has also remained 330 consistent over time, we propose that environmental factors may be mediating the observed 331 changes in VREfm epidemiology. Further studies are needed to investigate this hypothesis. 332
In addition to gaining new insights in vanA epidemiology in this context, we have also 333 provided valuable information on vanB-VREfm; given that we found genetic diversity was 334 slightly lower across hospitals compared to within, this suggests a potential community 335 reservoir for these strains. Transmission of VREfm has previously been shown in nursing 336
homes (67), with carriage strains closely related to those causing infection; investigation is 337 warranted to determine if this is also the case for Victoria. The seemingly widespread 338 diversity of vanB VREfm could also be due to a "diffusion" effect, wherein colonization and 339 infection have slowly spread across hospitals through many years of patient exchanges. Such 340 a pattern would be reminiscent of that observed in Denmark (68); however, while in 341
Denmark the "diffusion" process was marked by a hub-and-spoke pattern, with patients 342 mainly being exchanged between regional hospitals and central hospitals in Copenhagen, in 343 Victoria, the process was likely more random. If such a "diffusion" scenario is correct, we 344 hypothesize that the pattern of genetic diversity of vanA-VREfm will eventually mirror that 345 of the vanB. 346
This work has a number of key strengths. Firstly, by including >99% of VREfm 347 collected in Victoria over this one-month period, we have provided a comprehensive 348 assessment of local strain diversity and the prevalence of clinically-relevant van genotypes, 349 as well as a baseline to monitor for changes in VREfm population in Victoria. Secondly, we 350 used local reference genomes for all SNP-based analyses. As using more genetically-distantreference genomes can result in false positive SNPs, and/or loss of information due to 352 differences in genes present in the study sample, but not in the reference, this increased the 353 accuracy of our short-read analyses. Since the first complete E. faecium genome was 354 published by our group in 2012 (69), few other genomes have been completed; by sharing 355 these complete VREfm genomes (from five different STs), we are also providing an 356 invaluable resource for public health as well as future studies on E. faecium. Finally, the use 357 of long-read data has also allowed us to completely assemble and characterize the vanA-358 harbouring plasmids in each of the different STs -a task that is not always feasible with 359 short-read data alone. 360
There are several limitations of this work. Firstly, screening protocols for VREfm 361 colonization are not standardized across Victoria; each hospital adhered to its own infection 362 control guidelines, and as such, there may be incomplete capture of colonizing strains in this 363 dataset. This may bias our dataset somewhat towards strains causing clinical infection, and 364 cause us to miss potential transmission. Another limitation is that we did not have any data on 365 patient contact or intra-hospital transfer (except where isolates were collected at different 366 hospitals) -preventing us from confirming direct person-to-person transmission events. 367
However, we do not think this affects our overall population-level inferences, given the 368 dramatically lower genetic diversity of vanA within hospitals compared to vanB. Finally, as 369 this was predominantly a lab-based study, we also did not have data on clinical presentation 370 at time of sample collection and were therefore unable to discriminate clinical infection aside 371 from bacteremia. Thus, we may have underestimated the overall prevalence of infection 372 (though the most clinically important cases -associated with bacteremia -have been 373 included). 374
Herein, we have provided a comprehensive snapshot of VREfm strain diversity across 375 Victoria. We highlight the complexity of E. faecium genomic epidemiology, revealing key Isolates that were both vanA and vanB-positive (n=2), and isolates that were vanA and vanB-negative (n=10) were excluded from Panels B and C. 
